Successful hyaluronic acid filler injection in a chronic myeloid leukemia patient taking imatinib mesylate

被引：2
作者：
Sung, Yegyu [1 ]
Kim, Min Hee [2 ]
Cho, Eujin [3 ,4 ]
机构：
[1] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Internal Med, Daejeon, South Korea
[2] Catholic Univ Korea, Coll Med, St Pauls Hosp, Div Endocrinol,Dept Internal Med, Seoul, South Korea
[3] Korea Adv Inst Sci & Technol, Dept Dermatol, 291 Daehak Ro, Daejeon, South Korea
[4] DeRAMA Dermatol Clin, Dept Dermatol, 303 Eonju Ro, Seoul, South Korea
来源：
JOURNAL OF COSMETIC AND LASER THERAPY | 2019年 / 21卷 / 04期
关键词：
Chronic myeloid leukemia; filler; hyaluronic acid; imatinib mesylate; TOLERABILITY; EFFICACY; ZYPLAST; BLIND;
D O I：
10.1080/14764172.2018.1525745
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Dermal fillers are highly favored around the globe as minimally invasive or nonsurgical procedures. Imatinib mesylate is the first-line treatment for patients diagnosed with chronic myeloid leukemia. However, some studies describe that imatinib mesylate may increase the tendency of skin fragility which can lead to easy bruising and hyperpigmentation after invasive skin procedures. Yet, to our knowledge, no studies have described any successful dermal filler injection performed on patients who are under imatinib mesylate treatment. Hence, we present a case successfully treated with hyaluronic acid filler injection on a patient under imatinib mesylate treatment. We carefully propose that hyaluronic acid filler can be an effective means of rejuvenation and cosmetic enhancement for those under imatinib mesylate treatment.
引用
收藏
页码：243 / 244
页数：2
相关论文
共 8 条
[1]   Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib [J].
Amitay-Laish, Iris ;
Stemmer, Salomon M. ;
Lacouture, Mario E. .
DERMATOLOGIC THERAPY, 2011, 24 (04) :386-395
[2]   Systematic Review of Clinical Trials of Small- and Large-Gel-Particle Hyaluronic Acid Injectable Fillers for Aesthetic Soft Tissue Augmentation [J].
Cohen, Joel L. ;
Dayan, Steven H. ;
Brandt, Fredric S. ;
Nelson, Diane B. ;
Axford-Gatley, Robert A. ;
Theisen, Michael J. ;
Narins, Rhoda S. .
DERMATOLOGIC SURGERY, 2013, 39 (02) :205-231
[3]   Dermal fillers in aesthetics: an overview of adverse events and treatment approaches [J].
Funt, David ;
Pavicic, Tatjana .
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2013, 6 :295-316
[4]   Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib [J].
Gambacorti-Passerini, Carlo ;
Antolini, Laura ;
Mahon, Francois-Xavier ;
Guilhot, Francois ;
Deininger, Michael ;
Fava, Carmen ;
Nagler, Arnon ;
Della Casa, Chiara Maria ;
Morra, Enrica ;
Abruzzese, Elisabetta ;
D'Emilio, Anna ;
Stagno, Fabio ;
le Coutre, Philipp ;
Hurtado-Monroy, Rafael ;
Santini, Valeria ;
Martino, Bruno ;
Pane, Fabrizio ;
Piccin, Andrea ;
Giraldo, Pilar ;
Assouline, Sarit ;
Durosinmi, Muheez A. ;
Leeksma, Onno ;
Pogliani, Enrico Maria ;
Puttini, Miriam ;
Jang, Eunjung ;
Reiffers, Josy ;
Valsecchi, Maria Grazia ;
Kim, Dong-Wook .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (07) :553-561
[5]   Contemporary Review of Injectable Facial Fillers [J].
Kontis, Theda C. .
JAMA FACIAL PLASTIC SURGERY, 2013, 15 (01) :58-64
[6]   A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds [J].
Lindqvist, C ;
Tveten, S ;
Bondevik, BE ;
Fagrell, D .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2005, 115 (01) :282-289
[7]   A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds [J].
Narins, RS ;
Brandt, F ;
Leyden, J ;
Lorenc, ZP ;
Rubin, M ;
Smith, S .
DERMATOLOGIC SURGERY, 2003, 29 (06) :588-595
[8]   Imatinib mesylate causes hypopigmentation in the skin [J].
Tsao, AS ;
Kantarjian, H ;
Cortes, J ;
O'Brien, S ;
Talpaz, M .
CANCER, 2003, 98 (11) :2483-2487
1